nach oben

01.04.2010 | Riley Symposium

MicroRNAs in Cardiac Development and Remodeling

verfasst von: Da-Zhi Wang

Erschienen in: Pediatric Cardiology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs (miRNAs) are a class of highly conserved, small, noncoding RNAs that play roles in a wide range of biologic processes. Dysregulated miRNA expression has been associated with human cardiovascular disease, and studies using animal models have shown that miRNAs are essential for cardiac development and remodeling. These previously unrecognized small molecules shed new light on the regulatory mechanisms underlying cardiac development and pathology, suggesting the potential importance of miRNAs as diagnostic markers and therapeutic targets for cardiovascular disease.

Andl T, Murchison EP, Liu F, Zhang Y, Yunta-Gonzalez M, Tobias JW et al (2006) The miRNA-processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles. Curr Biol 16:1041–1049CrossRefPubMed

Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R et al (2005) Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122:553–563CrossRefPubMed

Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al (2003) Dicer is essential for mouse development. Nat Genet 35:215–217CrossRefPubMed

Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP et al (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119:2772–2786CrossRefPubMed

Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613–638CrossRefPubMed

Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029–6033CrossRefPubMed

Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM et al (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228–233CrossRefPubMed

Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z et al (2008) Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA 105:211–216

Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290–1297CrossRefPubMed

10.

Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H et al (2007) MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy? Am J Pathol 170:1831–1840CrossRefPubMed

11.

Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B et al (2006) A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38:813–818CrossRefPubMed

12.

Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M et al (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3:87–98CrossRefPubMed

13.

Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45–79CrossRefPubMed

14.

Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S et al (2005) MicroRNAs regulate brain morphogenesis in zebrafish. Science 308:833–838CrossRefPubMed

15.

Griffiths-Jones S, Saini HK, Dongen SV, Enright AJ (2007) miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154–D158CrossRefPubMed

16.

Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ (2005) The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci USA 102:10898–10903CrossRefPubMed

17.

Harris KS, Zhang Z, McManus MT, Harfe BD, Sun X (2006) Dicer function is essential for lung epithelium morphogenesis. Proc Natl Acad Sci USA 103:2208–2213CrossRefPubMed

18.

Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589–600CrossRefPubMed

19.

Humphreys DT, Westman BJ, Martin DI, Preiss T (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA 102:16961–16966CrossRefPubMed

20.

Hunter JJ, Chien KR (1999) Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341:1276–1283CrossRefPubMed

21.

Kiriakidou M, Tan GS, Lamprinaki S, De Planell-Saguer M, Nelson PT, Mourelatos Z (2007) An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell 129:1141–1151CrossRefPubMed

22.

Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al (2005) Combinatorial microRNA target predictions. Nat Genet 37:495–500CrossRefPubMed

23.

Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al (2005) Silencing of microRNAs in vivo with “antagomirs”. Nature 438:685–689CrossRefPubMed

24.

Lee SJ (2004) Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 20:61–86CrossRefPubMed

25.

Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20CrossRefPubMed

26.

Mandel EM, Callis TE, Wang DZ, Conlon FL (2005) Transcriptional mechanisms of congenital heart disease. Drug Discov Today 2:33–38PubMed

27.

Mardis ER (2008) The impact of next-generation sequencing technology on genetics. Trends Genet 24:133–141PubMed

28.

O’Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ et al (2007) Essential role for Dicer during skeletal muscle development. Dev Biol 311:359–368CrossRefPubMed

29.

Olson EN (2004) A decade of discoveries in cardiac biology. Nat Med 10:467–474CrossRefPubMed

30.

Olson EN (2006) Gene regulatory networks in the evolution and development of the heart. Science 313:1922–1927CrossRefPubMed

31.

Ransom J, Srivastava D (2007) The genetics of cardiac birth defects. Semin Cell Dev Biol 18:132–139CrossRefPubMed

32.

Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF (2006) Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci USA 103:8721–8726CrossRefPubMed

33.

Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al (2008) Heart disease and stroke statistics―2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25–e146CrossRefPubMed

34.

Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100:416–424CrossRefPubMed

35.

Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W et al (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350:2682–2688CrossRefPubMed

36.

Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY (2006) miR-21-mediated tumor growth. Oncogene 26:2799–2803CrossRefPubMed

37.

Srivastava D, Thomas T, Lin Q, Kirby ML, Brown D, Olson EN (1997) Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet 16:154–160CrossRefPubMed

38.

Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M et al (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42:1137–1141CrossRefPubMed

39.

Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW et al (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116:258–267CrossRefPubMed

40.

van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575–579CrossRefPubMed

41.

van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD et al (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103:18255–18260CrossRefPubMed

42.

Wienholds E, Koudijs MJ, van Eeden FJ, Cuppen E, Plasterk RH (2003) The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat Genet 35:217–218CrossRefPubMed

43.

Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, de Bruijn E et al (2005) MicroRNA expression in zebrafish embryonic development. Science 309:310–311CrossRefPubMed

44.

Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N et al (2007) MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 282:12363–12367CrossRefPubMed

45.

Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H et al (2007) The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120:3045–3052CrossRefPubMed

46.

Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B et al (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13:486–491CrossRefPubMed

47.

Zhao Y, Samal E, Srivastava D (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214–220CrossRefPubMed

48.

Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN et al (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1–2. Cell 129:303–317CrossRefPubMed

Titel: MicroRNAs in Cardiac Development and Remodeling
verfasst von: Da-Zhi Wang
Publikationsdatum: 01.04.2010
Verlag: Springer-Verlag
Erschienen in: Pediatric Cardiology / Ausgabe 3/2010
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-010-9641-9

Neu im Fachgebiet Kardiologie

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

MicroRNAs in Cardiac Development and Remodeling

Abstract

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie